|
|
||||
|
|
||||
|
||||
Symposium on Low-Grade Glioma |
Division of Radiation Oncology (P.D.B.), Division of Medical Oncology (J.C.B.), and Division of Neuro-Oncology (J.H.U.), Mayo Clinic, Rochester, MN 55905, USA; and Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA (E.G.S.)
2 Address correspondence to Paul D. Brown, Mayo Clinic, 200 First Street S.W., Rochester, MN 55905, USA (brown.paul{at}mayo.edu).
Abstract
Radiotherapy is a component of the treatment regimen for the majority of patients with low-grade gliomas. Therefore, the effect of radiotherapy on the long-term cognitive performance of these patients is a major concern. This article reviews the neurocognitive effects of radiotherapy on patients with low-grade gliomas. The weight of evidence suggests only sporadic, limited neurocognitive damage from focal radiotherapy at the doses usually prescribed for low-grade gliomas.
This article has been cited by other articles:
![]() |
D. Schiff, P. D. Brown, and C. Giannini Outcome in adult low-grade glioma: The impact of prognostic factors and treatment Neurology, September 25, 2007; 69(13): 1366 - 1373. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lebrun, D. Fontaine, A. Ramaioli, F. Vandenbos, S. Chanalet, M. Lonjon, J. F. Michiels, V. Bourg, P. Paquis, M. Chatel, et al. Long-term outcome of oligodendrogliomas Neurology, May 25, 2004; 62(10): 1783 - 1787. [Abstract] [Full Text] [PDF] |
||||
|
|